TechCrunch Startup News
Level Zero Health banks $6.9M to prove wearable medtech can take the strain out of hormone testing
Feb 20, 2025
A pioneering female-founded startup has secured $6.9 million in funding to develop a revolutionary wearable device for continuous hormone monitoring. This innovation aims to enhance women's health through non-invasive technology while tackling the challenges of regulatory approval. With a focus on improving hormone testing accuracy, the company is poised to make significant advancements in diagnostics for both men and women, marking a new era in medtech solutions.
07:43
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Level Zero Health secured $6.9 million in pre-seed funding to develop a wearable device for continuous hormone monitoring.
- The startup aims to revolutionize hormonal health monitoring for both women and men, emphasizing inclusivity in medical technology.
Deep dives
Innovative Hormone Monitoring Technology
Level Zero Health is developing a continuous hormone monitoring device that aims to eliminate the need for invasive blood draws. This startup has secured $6.9 million in pre-seed funding and plans to create a new market similar to the success of continuous glucose monitors (CGMs). The initial product will be a single-use, patch-like device that can detect hormone levels through interstitial fluid, providing immediate data for use cases like IVF. Eventually, the company aims to release a wearable that continuously measures hormones such as progesterone, estrogen, and testosterone, potentially transforming the understanding of hormonal roles in human biology.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
